These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19815032)

  • 1. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
    Dencker D; Husum H
    Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the new antiepileptic drug retigabine in a rodent model of mania.
    Dencker D; Dias R; Pedersen ML; Husum H
    Epilepsy Behav; 2008 Jan; 12(1):49-53. PubMed ID: 18086455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
    Redrobe JP; Nielsen AN
    Behav Brain Res; 2009 Mar; 198(2):481-5. PubMed ID: 19162078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine sensitization as a model of mania: comparative study of the effects of repeated lithium or carbamazepine administration.
    Grappi S; Marchese G; Secci ME; De Montis MG; Gambarana C; Scheggi S
    Pharmacol Biochem Behav; 2011 Oct; 99(4):749-58. PubMed ID: 21741986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
    Arban R; Maraia G; Brackenborough K; Winyard L; Wilson A; Gerrard P; Large C
    Behav Brain Res; 2005 Mar; 158(1):123-32. PubMed ID: 15680200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
    Flaisher-Grinberg S; Overgaard S; Einat H
    J Neurosci Methods; 2009 Feb; 177(1):44-50. PubMed ID: 18930764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
    Lan A; Einat H
    Behav Brain Res; 2019 Apr; 362():109-113. PubMed ID: 30630015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
    Macêdo DS; Medeiros CD; Cordeiro RC; Sousa FC; Santos JV; Morais TA; Hyphantis TN; McIntyre RS; Quevedo J; Carvalho AF
    Bipolar Disord; 2012 Nov; 14(7):707-18. PubMed ID: 22897629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
    Corrêa C; Amboni G; Assis LC; Martins MR; Kapczinski F; Streck EL; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):887-91. PubMed ID: 17367908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
    Frey BN; Andreazza AC; Rosa AR; Martins MR; Valvassori SS; Réus GZ; Hatch JP; Quevedo J; Kapczinski F
    Behav Pharmacol; 2006 Jun; 17(4):311-8. PubMed ID: 16914949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures.
    Pathak G; Ibrahim BA; McCarthy SA; Baker K; Kelly MP
    Neuropharmacology; 2015 Aug; 95():434-47. PubMed ID: 25959066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization, kindling, and anticonvulsants in mania.
    Post RM; Weiss SR
    J Clin Psychiatry; 1989 Dec; 50 Suppl():23-30; discussion 45-7. PubMed ID: 2689434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment.
    McNamara RK; Sullivan J; Richtand NM
    J Psychiatr Res; 2008 May; 42(6):458-68. PubMed ID: 17628596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
    Frey BN; Valvassori SS; Réus GZ; Martins MR; Petronilho FC; Bardini K; Dal-Pizzol F; Kapczinski F; Quevedo J
    J Psychiatry Neurosci; 2006 Sep; 31(5):326-32. PubMed ID: 16951735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K(v) 7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β.
    Kristensen LV; Sandager-Nielsen K; Hansen HH
    J Neurochem; 2012 May; 121(3):373-82. PubMed ID: 22356228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.
    Einat H; Yuan P; Szabo ST; Dogra S; Manji HK
    Neuropsychobiology; 2007; 55(3-4):123-31. PubMed ID: 17641532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Kalinichev M; Dawson LA
    Int J Neuropsychopharmacol; 2011 Sep; 14(8):1051-67. PubMed ID: 21208504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
    Einat H
    Pharmacol Rep; 2014 Aug; 66(4):722-5. PubMed ID: 24948079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors.
    Zhou Z; Wang Y; Tan H; Bharti V; Che Y; Wang JF
    Neurosci Lett; 2015 Aug; 603():84-8. PubMed ID: 26219985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
    Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.